For the Inventor, By the Inventor

Enter assignee name

Germantown, MD, United States of America

Qiagen Sciences, LLC

USPTO Granted Patents = 63

% Expired Patents = 12.7

CIPO Patents = 3

EPO Patents = 34

Trademarks = 25

Forward Citations = 114

Loading Chart...

Loading Chart...

85 inventors (with patents filed for the assignee):

Yexun Wang (15 out of 17 patents)

Jerzy Olejnik (14 out of 84 patents)

Steven Jeffrey Gordon (10 out of 37 patents)

4. Quan Peng (9 out of 10 patents)

5. Varouj D Amirkhanian (8 out of 26 patents)

6. Ming-Sun Liu (6 out of 15 patents)

7. Eddie Adams (5 out of 6 patents)

8. Mong Sano Marma (5 out of 9 patents)

9. Mark N Brolaski (4 out of 8 patents)

10. Vikram Devgan (4 out of 4 patents)

11. Ruben Salinas (3 out of 6 patents)

12. Anthony Ausiello (3 out of 4 patents)

13. Heather Callahan (3 out of 3 patents)

14. Victoria Nieciecki (3 out of 3 patents)

15. Michel Georges Perbost (3 out of 5 patents)

Core Competencies:

Analyte Enrichment

RNA Sequencing

Nucleic Acid Isolation

Microfluidic Device

DNA Quality Assessments

Multiplex PCR

Nucleotide Analogues

Detection Methods

Sample Preparation

Flow Cells

Genotyping

Bio-Analysis

63 patents: Sort by Forward Citations

1. 12674195 - METHODS AND KITS FOR HIGHLY MULTIPLEX SINGLE PRIMER EXTENSION (2026-07-07),

2. 12559785 - Analyte Enrichment Methods and Compositions (2026-02-24),

3. 12545950 - Methods for Preparing CDNA Samples for RNA Sequencing, and CDNA Samples and Uses Thereof (2026-02-10),

4. 12415999 - Nucleic acid isolation and inhibitor removal from complex samples (2025-09-16),

5. 12398391 - Semi-random barcodes for nucleic acid analysis (2025-08-26),

6. 12371740 - Primers with self-complementary sequences for multiple displacement amplification (2025-07-29),

7. 12215314 - Integrative DNA and RNA library preparations and uses thereof (2025-02-04),

8. 12066436 - Compositions and methods for diagnosing Lyme disease and for predicting Lyme disease spirochete elimination after treatment (2024-08-20),

9. 11821028 - Single end duplex DNA sequencing (2023-11-21),

10. 11819851 - Microfluidic device with vented microchambers (2023-11-21),

11. 11814618 - Methods for co-isolation of nucleic acids and proteins (2023-11-14),

12. 11725203 - Small-molecule mediated size selection of nucleic acids (2023-08-15),

13. 11401548 - Primers with self-complementary sequences for multiple displacement amplification (2022-08-02),

14. 11371092 - Detection device and methods of use (2022-06-28),

15. 11359237 - Modular flow cells and methods of sequencing (2022-06-14),

Company Overview

Qiagen Sciences, LLC, based in Germantown, MD, specializes in nucleic acid analysis, focusing on technologies that enhance the study and manipulation of genetic material. The company develops innovative solutions for analyte enrichment, RNA sequencing, and nucleic acid isolation, catering to the needs of research and clinical laboratories. Its expertise extends to microfluidic devices, DNA quality assessments, and multiplex PCR, positioning Qiagen as a leader in detection methods and nucleotide analogues within the biotechnology sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

63 Patents

#4 in Germantown, MD

#54 in Maryland

#5,767 in US

#11,640 in the World

Germantown, MD, United States of America

Qiagen Sciences, LLC

Forward Citations = 114

85 inventors:

Yexun Wang (15 out of 17 patents)

Jerzy Olejnik (14 out of 84 patents)

Steven Jeffrey Gordon (10 out of 37 patents)

4. Quan Peng (9 out of 10 patents)

5. Varouj D Amirkhanian (8 out of 26 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Qiagen Sciences, LLC. Retrieved from https://idiyas.com/company/qiagen-sciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…